Research and analysis

COVID-19: UKHSA laboratory assessments of inactivation methods

UKHSA has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.

• From: UK Health Security Agency
• Published: 23 December 2022

Documents

HCM-CoV2-106-v2-InhibiSURE-Viral-inactivation-Medium-TCF

Ref: GOV-13922

PDF, 250 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The UK Health Security Agency (UKHSA) has undertaken assessments of inactivation methods against SARS-CoV-2.

The assessment of each inactivation method is summarised in an individual report.

These reports will be useful for COVID-19 testing laboratories developing workflows that include an inactivation step and will aid the generation of suitable and sufficient risk assessments.

These assessments were previously published by Public Health England.

Published 23 December 2022